Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 6
2022 4
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial.
Dizman N, Meza L, Bergerot P, Alcantara M, Dorff T, Lyou Y, Frankel P, Cui Y, Mira V, Llamas M, Hsu J, Zengin Z, Salgia N, Salgia S, Malhotra J, Chawla N, Chehrazi-Raffle A, Muddasani R, Gillece J, Reining L, Trent J, Takahashi M, Oka K, Higashi S, Kortylewski M, Highlander SK, Pal SK. Dizman N, et al. Among authors: malhotra j. Nat Med. 2022 Apr;28(4):704-712. doi: 10.1038/s41591-022-01694-6. Epub 2022 Feb 28. Nat Med. 2022. PMID: 35228755 Free PMC article. Clinical Trial.
Editorial Comment.
Zengin ZB, Malhotra J, Pal SK. Zengin ZB, et al. Among authors: malhotra j. J Urol. 2021 Aug;206(2):251. doi: 10.1097/JU.0000000000001768.02. Epub 2021 May 4. J Urol. 2021. PMID: 33940926 No abstract available.
Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors.
Chawla NS, Sayegh N, Tripathi N, Govindarajan A, Zengin ZB, Phillip EJ, Dizman N, Meza L, Muddasani R, Chehrazi-Raffle A, Malhotra J, Hsu J, Agarwal N, Pal SK, Tripathi A. Chawla NS, et al. Among authors: malhotra j. Clin Genitourin Cancer. 2023 Feb;21(1):69-75. doi: 10.1016/j.clgc.2022.11.007. Epub 2022 Nov 18. Clin Genitourin Cancer. 2023. PMID: 36509613
Patients' Perceptions Regarding the Relevance of Items Contained in the Functional Assessment of Cancer Therapy Kidney Symptom Index-19.
Bergerot CD, Malhotra J, Bergerot P, Philip EJ, Castro DV, Hsu J, Mota ACA, Cardoso de Azeredo A, Neto JNM, Hutson T, Grünwald V, Bex A, Psutka SP, Rini B, Plimack ER, Master V, Albiges L, Choueiri TK, Pal S, Powles T. Bergerot CD, et al. Among authors: malhotra j. Oncologist. 2023 Jun 2;28(6):494-500. doi: 10.1093/oncolo/oyad028. Oncologist. 2023. PMID: 36917626 Free PMC article.
Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma.
Chehrazi-Raffle A, Muddasani R, Dizman N, Hsu J, Meza L, Zengin ZB, Malhotra J, Chawla N, Dorff T, Contente-Cuomo T, Dinwiddie D, McDonald BR, McDaniel T, Trent JM, Baehner FL, Murtaza M, Pal SK. Chehrazi-Raffle A, et al. Among authors: malhotra j. JCO Precis Oncol. 2023 Apr;7:e2200543. doi: 10.1200/PO.22.00543. JCO Precis Oncol. 2023. PMID: 37027813 Free PMC article.
Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort Analysis.
Meza L, Zengin Z, Salgia S, Malhotra J, Karczewska E, Dorff T, Tripathi A, Ely J, Kelley E, Mead H, Hsu J, Dizman N, Salgia N, Chawla N, Chehrazi-Raffle A, Muddasani R, Govindarajan A, Rock A, Liu S, Salgia R, Trent J, Altin J, Pal SK. Meza L, et al. Among authors: malhotra j. Oncologist. 2023 Sep 7;28(9):e748-e755. doi: 10.1093/oncolo/oyad067. Oncologist. 2023. PMID: 36971500 Free PMC article.
Perceptions of COVID-19 Vaccination in Patients with Genitourinary Cancers: A Survey Study.
Castro DV, Zengin ZB, Malhotra J, Bergerot CD, Meza L, Dizman N, Govindarajan A, Hsu J, Chehrazi-Raffle A, Chawla N, Mercier BD, Chen SW, Feng M, Prajapati S, Lee KO, Philip EJ, Dorff TB, Lyou Y, Pal SK. Castro DV, et al. Among authors: malhotra j. Cancer Invest. 2023 Jan;41(1):70-76. doi: 10.1080/07357907.2022.2136683. Epub 2023 Jan 5. Cancer Invest. 2023. PMID: 36239609
18 results